Medicinal cannabis and driving

The intersection of health and road safety policy

Datos Bibliográficos

ID14907104
AutoresDaniel Perkins (0000-0002-2055-1649, The University of Melbourne, autor de correspondencia), Hugh Brophy, Iain S McGregor (0000-0002-9307-7159, The University of Sydney), Paula O’Brien (0000-0002-6879-0489, The University of Melbourne), Paula O'Brien, Julia Quilter (0000-0002-8348-6741, University of Wollongong), Luke Mcnamara (0000-0002-8479-6469, UNSW Sydney), Jerome Sarris (0000-0001-9287-8854, Melbourne Clinic), Mark Stevenson (0000-0003-3166-5876, The University of Melbourne), Penny Gleeson (0000-0003-2798-1649, Deakin University), Justin Sinclair (0000-0001-9960-3191, Western Sydney University), Paul Dietze (0000-0001-7871-6234, Burnet Institute)
Año2021
Volumen97
Páginas103307
Fecha de publicación2021-11-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Drug Policy (JOURNAL)
Identificadores de la revistaISSN: 0955-3959 • E-ISSN: 1873-4758
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2021.103307
PMID34107448
OpenAlexW3167517561
IdiomaEN
Citas recibidas5
Referencias citadas63

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects

Cannabis · Environmental health · Intersection (aeronautics · Occupational safety and health · Poison control · Political science · Psychiatry · Suicide prevention · Transport engineering · Cannabis and Cannabinoid Research · Engineering · Forensic Toxicology and Drug Analysis · Law · Medicine · Prenatal Substance Exposure Effects · Psychology